Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-103.65%
operating margin TTM
-116.83%
revenue TTM
20.66 Million
revenue per share TTM
1.31$
valuation ratios | |
|---|---|
| pe ratio | -5.75 |
| peg ratio | -1.06 |
| price to book ratio | 1.21 |
| price to sales ratio | 12.32 |
| enterprise value multiple | -11.48 |
| price fair value | 1.21 |
profitability ratios | |
|---|---|
| gross profit margin | 18.25% |
| operating profit margin | -116.83% |
| pretax profit margin | -103.44% |
| net profit margin | -103.65% |
| return on assets | -16.06% |
| return on equity | -59.01% |
| return on capital employed | -23.28% |
liquidity ratios | |
|---|---|
| current ratio | 4.44 |
| quick ratio | 4.44 |
| cash ratio | 0.42 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 8.95 |
| days of payables outstanding | 20.20 |
| cash conversion cycle | -11.25 |
| receivables turnover | 40.78 |
| payables turnover | 18.07 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -20.23 |
cash flow ratios | |
|---|---|
| free cash flow per share | -7.29 |
| cash per share | 30.38 |
| operating cash flow per share | -7.28 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -20.23 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -1,327.07 |
Frequently Asked Questions
When was the last time Assembly Biosciences, Inc. (NASDAQ:ASMB) reported earnings?
Assembly Biosciences, Inc. (ASMB) published its most recent earnings results on 10-11-2025.
What is Assembly Biosciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Assembly Biosciences, Inc. (NASDAQ:ASMB)'s trailing twelve months ROE is -59.01%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Assembly Biosciences, Inc. (ASMB) currently has a ROA of -16.06%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ASMB's net profit margin stand at?
ASMB reported a profit margin of -103.65% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ASMB's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.44 in the most recent quarter. The quick ratio stood at 4.44, with a Debt/Eq ratio of 0.02.